Jim Cramer Suggests Waiting for Clarity on ImmunityBio Before Taking a “Hard Look”
Summary
ImmunityBio, Inc. (NASDAQ:IBRX) was among Jim Cramer’s recent stock calls on Mad Money. Answering a caller’s query about the stock during the recent lightni...
Description
ImmunityBio, Inc. (NASDAQ:IBRX) was among Jim Cramer’s recent stock calls on Mad Money. Answering a caller’s query about the stock during the recent lightni...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source